METASTATIC PROSTATE SMALL CELL NEUROENDOCRINE CARCINOMA
Clinical trials for METASTATIC PROSTATE SMALL CELL NEUROENDOCRINE CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC PROSTATE SMALL CELL NEUROENDOCRINE CARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC PROSTATE SMALL CELL NEUROENDOCRINE CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare cancers: Triple-Threat therapy trial opens
Disease control Recruiting nowThis study is testing a combination of three drugs—cabozantinib, nivolumab, and ipilimumab—for patients with rare types of bladder, kidney, penile, and other urinary tract cancers that have spread. The goal is to see if this three-drug approach can shrink tumors and control the d…
Matched conditions: METASTATIC PROSTATE SMALL CELL NEUROENDOCRINE CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC
-
Radioactive 'Tumor-Seeker' drug tested for Tough-to-Treat prostate cancer
Disease control Recruiting nowThis study is testing an experimental radioactive drug called lutetium Lu 177 dotatate for men with an aggressive form of prostate cancer that has spread and developed neuroendocrine features. The drug is designed to find and deliver radiation directly to cancer cells. The main g…
Matched conditions: METASTATIC PROSTATE SMALL CELL NEUROENDOCRINE CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 10, 2026 12:53 UTC